Versuchen GOLD - Frei
AI, biotech & telemedicine shaping future of healthcare
Chronicle Pharmabiz
|November 27, 2025
The healthcare sector in India is undergoing a dramatic transformation due to the increasing use of Artificial Intelligence (AI), remote medical services, and advancements in biotechnology.
India, with its vast population of over 1.4 billion, encounters major difficulties such as unequal healthcare access between cities and rural areas, restricted availability of good healthcare, a lack of medical staff, and an increasing number of long-term illnesses. Conventional healthcare models alone cannot effectively handle these problems, making innovation essential for enhancing accessibility, affordability, and the standard of healthcare provided.
In the last 10 years, India has seen a significant increase in the use of digital health technologies, AI-powered diagnostic tools, and biological research. The quick adoption of remote medical services and distant healthcare options was further propelled by the Covid-19 pandemic. Moreover, India has risen to prominence as a major center for cutting-edge biopharmaceutical development, especially in the fields of vaccinations, biosimilar medications, and innovative treatments.
Role of AI in Indian healthcare
The integration of Artificial Intelligence is revolutionizing India's healthcare system by improving diagnostic procedures, making predictive analysis possible, and making administrative duties and clinical procedures more efficient. AI-driven formulas can analyze huge amounts of data to find trends, predict how diseases will progress, and help healthcare providers make decisions, which lowers the risk of errors and makes things run more smoothly.
AI systems are now being used to spot illnesses in their initial phases, which is a huge advancement in diagnostics. For example, Niramai uses thermal imaging that is powered by AI to look for breast cancer, making detection affordable, noninvasive, and radiation-free.
Diese Geschichte stammt aus der November 27, 2025-Ausgabe von Chronicle Pharmabiz.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Chronicle Pharmabiz
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
